Related Experiment Video
Updated: Jun 7, 2026
09:30
Pre-Implantation Genetic Testing for Aneuploidy on a Semiconductor Based Next-Generation Sequencing Platform
Published on: August 17, 2022
Parental preferences for CDKN2A/p16 testing of minors.
Jennifer M Taber1, Lisa G Aspinwall, Wendy Kohlmann
1Department of Psychology, University of Utah, Salt Lake City, Utah 84112-0251, USA.
Summary
Most adults support genetic testing for minors regarding melanoma risk, believing it improves awareness and health behaviors. This preference for early detection and risk assessment remained consistent over time.
Area of Science:
- Genetics
- Dermatology
- Public Health
Background:
- Genetic testing in minors presents ethical challenges, influenced by disease specifics and family context.
- Melanoma has a known environmental component and benefits from early detection.
Purpose of the Study:
- To assess adult attitudes towards genetic testing for minors concerning melanoma.
- To understand the long-term stability of these attitudes.
Main Methods:
- Surveyed 61 adults from two kindreds with CDKN2A/p16 mutation testing.
- Collected data immediately post-testing and again 2 years later.
Main Results:
- 86.9% supported genetic testing for minors, citing risk awareness and improved screening behaviors.
- 82.6% of mutation carriers desired testing for their children; preferences were stable over 2 years.
- Most favored involving children in counseling, with few concerns about psychological distress.
Conclusions:
- Strong support exists for melanoma genetic testing in minors, primarily for enhanced health behaviors.
- The study offers insights into genetic counseling and testing strategies for minors in melanoma families.
